IRIS
PEA, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.525
EU - Europa 3.604
AS - Asia 1.499
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 19
SA - Sud America 8
OC - Oceania 1
Totale 19.677
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.476
UA - Ucraina 1.121
CN - Cina 632
DE - Germania 531
IT - Italia 531
SE - Svezia 482
SG - Singapore 423
RU - Federazione Russa 317
TR - Turchia 271
IE - Irlanda 214
FI - Finlandia 186
GB - Regno Unito 97
VN - Vietnam 75
CA - Canada 44
IN - India 42
BE - Belgio 36
EU - Europa 21
FR - Francia 19
CZ - Repubblica Ceca 18
NL - Olanda 13
IR - Iran 12
EG - Egitto 10
HK - Hong Kong 10
ID - Indonesia 10
RO - Romania 9
CH - Svizzera 8
KR - Corea 7
ES - Italia 6
JP - Giappone 5
RS - Serbia 5
BR - Brasile 4
MX - Messico 4
TG - Togo 4
TH - Thailandia 3
AR - Argentina 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
CM - Camerun 2
IL - Israele 2
PL - Polonia 2
SD - Sudan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
HU - Ungheria 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
PA - Panama 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 19.677
Salva come PNG Salva come JPEG
Città #
Fairfield 2.203
Woodbridge 1.561
Chandler 1.139
Houston 1.085
Ashburn 1.050
Ann Arbor 962
Wilmington 839
Seattle 828
Cambridge 715
Jacksonville 635
Dearborn 427
Boardman 349
Singapore 332
Beijing 269
Izmir 268
Princeton 237
Dublin 214
Udine 194
Des Moines 143
San Diego 124
Dong Ket 71
Falls Church 58
Redmond 57
New York 42
Norwalk 42
Ogden 40
Brussels 35
Nanjing 34
Grafing 33
Munich 29
Hefei 28
Ottawa 27
Shanghai 26
Grugliasco 22
Helsinki 21
Kunming 20
Guangzhou 19
Moscow 18
Jinan 17
Los Angeles 17
Milan 17
Brno 16
Dallas 16
San Mateo 15
Trieste 14
Bologna 13
Piemonte 12
West Jordan 12
Wuhan 12
Nanchang 11
Redwood City 11
Fuzhou 10
Naples 10
Changsha 9
Montreal 9
Simi Valley 9
Venezia 9
Amsterdam 8
Augusta 8
Rome 8
Monmouth Junction 7
Phoenix 7
Santa Clara 7
Verona 7
Washington 7
Bogor 6
Hyderabad 6
London 6
San Jose 6
Tappahannock 6
Zurich 6
Andover 5
Auburn Hills 5
Brescia 5
Chengdu 5
Hebei 5
Leawood 5
Nuremberg 5
Paris 5
Shenyang 5
Shenzhen 5
Taizhou 5
Tokyo 5
Wenzhou 5
Baotou 4
Edinburgh 4
Fremont 4
Hangzhou 4
Indiana 4
Lomé 4
Maserada Sul Piave 4
Napoli 4
Toronto 4
Al Qahirah al Jadidah 3
Ardabil 3
Belgrade 3
Buffalo 3
Canyon Country 3
Chiampo 3
Chicago 3
Totale 14.652
Salva come PNG Salva come JPEG
Nome #
A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds? 333
A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients? 322
A regional approach to Antimicrobial Stewardship: the Friuli Venezia Giulia program 213
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae? 195
Everolimus overexposure in a heart transplant patient receiving clarithromycin for the treatment of pneumonia 171
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 167
Ceftolozane/tazobactam for the treatment of MDR Pseudomonas aeruginosa left ventricular assist device infection as a bridge to heart transplant 160
Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with hematological malignancies 155
Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug Monitoring. 153
Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures. 148
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients 145
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients 142
Polypharmacy in an Italian Regional Health system: a survey on drugs use in different healthcare settings 139
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 138
Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations. 137
Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens 133
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy 133
Population pharmacokinetics and pharmacodynamics of levofloxacin in acutely hospitalized older patients with various degrees of renal function 133
Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients 131
Antiretroviral blood levels in HIV/HCV-coinfected patients with cirrhosis after liver transplant: A report of three cases 128
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 127
Linezolid underexposure in a patient co-treated with venlafaxine 127
Ceftolozane/tazobactam: place in therapy 125
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice? 124
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections 124
Is empiric daptomycin effective in reducing mortality in Staphylococcus aureus bacteraemia? A real-life experience 121
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. 120
Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus. 120
Antibiotic therapy in hematological neutropenic patients: what is the news? 119
Is MIC increase of meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae correlated with the increase of resistance rates against some other antibiotics with Gram-negative activity? 118
Treatment of consecutive episodes of multidrug-resistant bacterial pleurisy with different aetiology in a heart transplant candidate: Proof of concept of pharmacokinetic/pharmacodynamic optimisation of antimicrobial therapy at the infection site 118
Pharmacokinetics and drug metabolism of antibiotics in the elderly 118
Monitoring polypharmacy in healthcare systems through a multi-setting survey: Should we put more attention on long term care facilities? 117
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 116
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 116
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases. 116
Might isoniazid plasma exposure be a valuable predictor of drug-related hepatotoxicity risk among adult patients with TB? 116
Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp 116
Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful? 115
Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients 114
Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis 114
Biliary pharmacodynamic exposure to linezolid in two liver transplant patients. 114
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers. 114
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 113
Intra-abdominal penetration and pharmacodynamic exposure to fluconazole in three liver transplant patients with deep-seated candidiasis 112
- FLUCONAZOLE MONITORING IN LIVER TRANSPLANT RECIPIENTS 111
Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient 110
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions 110
Linezolid underexposure in a hypothyroid patient on levothyroxine replacement therapy: A case report 110
HIV-INFECTED PATIENTS AND LIVER TRANSPLANTATION: WHO, WHEN AND WHY 109
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures 109
Antimicrobial treatment of bacterial infections in frail elderly patients: The difficult balance between efficacy, safety and tolerability 108
Plasma pharmacokinetics of antimicrobial agents in critically Ill patients 108
Liposome-encapsulated daunorubicin for PGP-related multidrug resistance 108
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations 108
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia 107
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis 106
Procalcitonin-guided antibiotic therapy: An expert consensus 106
Pharmacokinetic/pharmacodynamic evaluation of linezolid in hospitalized paediatric patients: a step toward dose optimization by means of therapeutic drug monitoring and Monte Carlo simulation. 106
WSES consensus conference: Guidelines for first-line management of intra-abdominal infections 106
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring 105
Candida endocarditis and the impact of antifungal treatment on the corrected QT interval: a case report 104
The effect of pathophysiology on pharmacokinetics in the critically ill patient - Concepts appraised by the example of antimicrobial agents 104
Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy 104
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? 104
Urinary Pharmacokinetics and Theoretical Pharmacodynamics of Intravenous Levofloxacin in Intensive Care Unit Patients Treated with 500 mg b.i.d. for Ventilator-Associated Pneumonia 104
Effect of fluctuations of blood cyclosporine concentrations on renal function. 103
Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery 102
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 102
Biocompatibility and biodegradation of different hyaluronan derivatives (Hyaff) implanted in rats 102
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: A pharmacokinetics/pharmacodynamics-based approach 101
Drugs and blood cells 101
Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? 100
Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose 100
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast Italy 100
Gentamicin once-daily in enterococcal endocarditis 100
Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients 99
Practical concept of pharmacokinetics/pharmacodynamics in the management of skin and soft tissue infections 99
Reappraisal of Linezolid Dosing in Renal Impairment to Improve Safety 99
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review 98
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin 98
Effect of the number of samples on bayesian and non-linear least-squares individualization: A study of cyclosporin treatment of haematological patients with multidrug resistance 97
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 97
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 96
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective 96
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 96
A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care 96
Blood concentrations and clinical effect of cyclosporin in psoriasis 95
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 95
Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance 95
Daptomycin in solid organ transplantation: Consideration of dosage adjustments in renal impairment 94
Daptomycin underexposure in a young intravenous drug user who was affected by life-threatening Staphylococcus aureus-complicated skin and soft tissue infection associated with bacteraemia 94
Could de-escalation of antibiotic therapy be feasible even for documented methicillin-resistant staphylococcus aureus ventilator-associated pneumonia? 94
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin 93
Population pharmacokinetics and dosing considerations for the use of daptomycin in adult patients with haematological malignancies 93
Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections 93
Comparison of clinical characteristics of tuberculosis between two age groups at an Italian Tertiary Hospital 92
Bactericidal activity and synergistic effect versus gentamicin of neutropenic rats sera 92
Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients 92
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients 92
Totale 11.873
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.371
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.526 0 0 0 0 0 0 639 556 508 343 125 355
2020/20213.375 220 431 130 383 229 345 166 362 392 140 322 255
2021/20222.225 116 198 145 170 88 118 153 104 33 372 402 326
2022/20232.555 274 152 38 332 313 741 0 174 369 27 67 68
2023/2024668 126 53 20 10 114 79 20 57 71 40 28 50
2024/20251.278 111 318 216 126 137 198 172 0 0 0 0 0
Totale 20.364